Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
37.3M
-
Shares change
-
-2.12M
-
Total reported value, excl. options
-
$278M
-
Value change
-
-$12.8M
-
Put/Call ratio
-
0.37
-
Number of buys
-
62
-
Number of sells
-
-67
-
Price
-
$7.44
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q4 2024
161 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q4 2024.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.3M shares
of 63.2M outstanding shares and own 59.01% of the company stock.
Largest 10 shareholders include ARMISTICE CAPITAL, LLC (6.21M shares), BlackRock, Inc. (3.77M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.94M shares), VANGUARD GROUP INC (2.73M shares), MORGAN STANLEY (2.14M shares), JPMORGAN CHASE & CO (1.98M shares), CIBC Private Wealth Group LLC (1.89M shares), GAGNON SECURITIES LLC (1.77M shares), DEUTSCHE BANK AG\ (1.29M shares), and D. E. Shaw & Co., Inc. (1.12M shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.